HCPCS Level II
J1720
Injection, hydrocortisone sodium succinate, up to 100 mg
Codes near J1720
These sit next to J1720 in the CMS Level II file. All J codes
- J1655Injection, tinzaparin sodium, 1000 iu
- J1670Injection, tetanus immune globulin, human, up to 250 units
- J1675Injection, histrelin acetate, 10 micrograms
- J1700Injection, hydrocortisone acetate, up to 25 mg
- J1710Injection, hydrocortisone sodium phosphate, up to 50 mg
- J1725Injection, hydroxyprogesterone caproate, 1 mg
- J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730Injection, diazoxide, up to 300 mg
- J1736Injection, meloxicam (delova), 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00009-0005-01 | Solu-Cortef | Pfizer Inc | 10 |
| 00009-0011-03 | Solu-Cortef | Pfizer Inc | 1 |
| 00009-0011-04 | Solu-Cortef | Pfizer Inc | 25 |
| 00009-0013-05 | Solu-Cortef | Pfizer Inc | 3 |
| 00009-0013-06 | Solu-Cortef | Pfizer Inc | 75 |
| 00009-0016-12 | Solu-Cortef | Pfizer Inc | 5 |
| 00009-0825-01 | Solu-Cortef | Pfizer Inc | 1 |
| 51662-1261-01 | Solu-Cortef | HF Acquisition Co. LLC, DBA HealthFirst | 1 |
| 51662-1262-01 | Solu-Cortef | HF Acquisition Co. LLC, DBA HealthFirst | 3 |
| 60505-6411-00 | Hydrocortisone Sodium Succinate | Apotex Corp | 1 |
| 69097-0004-67 | Hydrocortisone Sodium Succinate | Cipla USA, Inc. | 1 |
| 70710-1907-01 | Hydrocortisone Sodium Succinate | Zydus Pharmaceuticals (USA) Inc. | 1 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.